**Core Concept**
Levetiracetam is an antiepileptic medication that works by modulating neurotransmitter release through binding to a synaptic vesicle protein, SV2A. This action is thought to stabilize neuronal membranes and prevent the initiation of seizures.

**Why the Correct Answer is Right**
Levetiracetam's unique mechanism of action involves the binding of its active metabolite to SV2A, which is involved in the regulation of neurotransmitter release. By binding to SV2A, levetiracetam reduces the excitability of neurons and prevents the synchronization of neuronal activity that can lead to seizures. This action is distinct from other antiepileptic medications, which often work by modulating ion channels or GABAergic transmission.

**Why Each Wrong Option is Incorrect**
**Option A:** Levetiracetam is not primarily used as an anxiolytic or hypnotic agent, unlike benzodiazepines, which are GABA_A receptor agonists.
**Option B:** Levetiracetam is not a first-line treatment for status epilepticus, which is typically managed with benzodiazepines or other rapid-acting antiepileptic medications.
**Option C:** Levetiracetam is not a muscle relaxant, unlike drugs like baclofen, which act on GABA_B receptors to reduce muscle tone.

**Clinical Pearl / High-Yield Fact**
Levetiracetam is effective in a broad range of seizure types, including generalized tonic-clonic seizures, partial seizures, and myoclonic seizures, making it a useful adjunctive therapy in patients with treatment-resistant epilepsy.

**Correct Answer: B. Levetiracetam is effective in partial seizures.**